Biotech Sector Continues Its Torrid Pace in Third Quarter
It wasn’t all that long ago that Amgen Inc. and Genentech Inc., prior to its acquisition by Basel, Switzerland-based Roche AG, both commanded impressive $100 billion market caps. Since that milestone was reached, valuations of the public biotech companies have declined, until recently that is.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST